Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Xinyanghe Biotechnology is a China-based high-tech enterprise specializing in the research, development, and large-scale production of pharmaceutical intermediates and fine chemicals. The company focuses on the synthesis of unnatural amino acids, nucleosides, and nucleotides, providing essential building blocks for the global pharmaceutical and biotechnology industries. With a strong emphasis on R&D and quality control, they offer custom synthesis and contract manufacturing services to support drug discovery and development. Their product portfolio serves as a foundation for various therapeutic areas, particularly in the development of small molecule drugs and biochemical reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Xinyanghe Biotechnology.